Elscint sells out to Picker and General Electric for $375 million
This article was originally published in Clinica
Elbit Medical Imaging has sold the Elscint magnetic resonance imaging (MRI), computed tomography (CT) and nuclear medicine business for a total of $375 million. Picker International is to pay $275 million for Elscint's CT division, while General Electric Medical Systems (GEMS) gets the MRI and nuclear medicine business for $100 million.
You may also be interested in...
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.